tradingkey.logo
tradingkey.logo
Search

Firefly Neuroscience Inc

AIFF
Add to Watchlist
1.700USD
-0.080-4.49%
Close 05/15, 16:00ETQuotes delayed by 15 min
23.74MMarket Cap
LossP/E TTM

Firefly Neuroscience Inc

1.700
-0.080-4.49%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Firefly Neuroscience Inc

Currency: USD Updated: 2026-05-15

Key Insights

Firefly Neuroscience Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 235 out of 468 in the Software & IT Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Firefly Neuroscience Inc's Score

Industry at a Glance

Industry Ranking
235 / 468
Overall Ranking
412 / 4482
Industry
Software & IT Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Firefly Neuroscience Inc Highlights

StrengthsRisks
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.14M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.14M.
Undervalued
The company’s latest PE is -4.74, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.05M shares, decreasing 41.27% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 0.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.80.

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of Firefly Neuroscience Inc is 7.11, ranking 235 out of 468 in the Software & IT Services industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 716.00K, representing a year-over-year increase of 1565.12%, while its net profit experienced a year-over-year increase of 87.92%.

Score

Industry at a Glance

Previous score
7.11
Change
0

Financials

9.33

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.28

Operational Efficiency

2.98

Growth Potential

8.67

Shareholder Returns

7.29

Firefly Neuroscience Inc's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of Firefly Neuroscience Inc is 8.18, ranking 110 out of 468 in the Software & IT Services industry. Its current P/E ratio is -4.74, which is -95.56% below the recent high of -0.21 and -104.30% above the recent low of -9.68.

Score

Industry at a Glance

Previous score
8.18
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 235/468
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

No earnings forecast score is currently available for Firefly Neuroscience Inc. The Software & IT Services industry's average is 7.61.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of Firefly Neuroscience Inc is 5.25, ranking 418 out of 468 in the Software & IT Services industry. Currently, the stock price is trading between the resistance level at 2.19 and the support level at 1.43, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
5.32
Change
-0.07

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.101
Neutral
RSI(14)
42.188
Neutral
STOCH(KDJ)(9,3,3)
10.008
Oversold
ATR(14)
0.153
Low Volatility
CCI(14)
-118.402
Sell
Williams %R
93.750
Oversold
TRIX(12,20)
-0.125
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
1.776
Sell
MA10
1.882
Sell
MA20
2.009
Sell
MA50
1.973
Sell
MA100
1.449
Buy
MA200
1.878
Sell

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of Firefly Neuroscience Inc is 3.00, ranking 282 out of 468 in the Software & IT Services industry. The latest institutional shareholding proportion is 5.19%, representing a quarter-over-quarter decrease of 53.77%. The largest institutional shareholder is The Vanguard, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Johnson (David Ian)
1.12M
+100.00%
Roxy Capital Corp.
424.69K
-38.46%
RJL 18 Capital Canada LP
499.37K
--
Windsor Private Capital LP
605.42K
-19.57%
Lipschitz (Gregory)
497.19K
+15.30%
Finn (Christopher)
349.22K
-19.76%
Jane Street Capital, L.L.C.
60.31K
--
UBS Financial Services, Inc.
24.70K
-63.95%
Menawat (Arun Swarup Ph.D.)
99.41K
--
Geode Capital Management, L.L.C.
113.32K
--
1
2

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Software & IT Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Firefly Neuroscience Inc is 2.03, ranking 387 out of 468 in the Software & IT Services industry. The company's beta value is 0.56. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
2.03
Change
0
Beta vs S&P 500 index
0.54
VaR
+11.72%
240-Day Maximum Drawdown
+81.07%
240-Day Volatility
+136.75%

Return

Best Daily Return
60 days
+126.28%
120 days
+126.28%
5 years
+170.97%
Worst Daily Return
60 days
-29.82%
120 days
-29.82%
5 years
-41.72%
Sharpe Ratio
60 days
+2.25
120 days
+0.97
5 years
+0.24

Risk Assessment

Maximum Drawdown
240 days
+81.07%
3 years
+96.33%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.57
3 years
-0.28
5 years
--
Skewness
240 days
+6.52
3 years
+5.98
5 years
+5.93

Volatility

Realised Volatility
240 days
+136.75%
5 years
--
Standardised True Range
240 days
+10.43%
5 years
--
Downside Risk-Adjusted Return
120 days
+308.46%
240 days
+308.46%
Maximum Daily Upside Volatility
60 days
+435.60%
Maximum Daily Downside Volatility
60 days
+165.56%

Liquidity

Average Turnover Rate
60 days
+74.75%
120 days
+38.18%
5 years
--
Turnover Deviation
20 days
-80.64%
60 days
+157.84%
120 days
+31.69%

Peer Comparison

Software & IT Services
Firefly Neuroscience Inc
Firefly Neuroscience Inc
AIFF
4.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Visa Inc
Visa Inc
V
8.75 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
VeriSign, Inc
VeriSign, Inc
VRSN
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Synopsys Inc
Synopsys Inc
SNPS
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
A10 Networks Inc
A10 Networks Inc
ATEN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Akamai Technologies Inc
Akamai Technologies Inc
AKAM
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI